| Product Name | MF | CAS | Details |
|---|
| Propan-2-yl 2-amino-2-methylpropanoate | C7H15NO2 | 131322-68-4 | Details |
| 2-Methyl-N-(pentan-3-yl)pyrazolo[1,5-a]quinazolin-5-amine | C16H20N4 | 874652-33-2 | Details |
| H-AEFAEVSK^-OH | Details |
| 4-Methyl-2-({[(4-methylphenyl)methyl]carbamoyl}amino)pentanoic acid | C15H22N2O3 | 1009260-27-8 | Details |
| tert-Butyl N-{[1-(aminomethyl)cyclopropyl]methyl}carbamate | C10H20N2O2 | 1147109-42-9 | Details |
| D,L-Mevalonic acid lactone | C6H10O3 | 674-26-0 | Details |
| 3-Methoxy-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C6H7N5O | 111375-22-5 | Details |
| tert-Butyl N-(2-ethoxycyclopropyl)carbamate | C10H19NO3 | 1803606-62-3 | Details |
| 3-Azabicyclo[3.1.0]hexane-3-carbonyl chloride | C6H8ClNO | 1463934-80-6 | Details |
| NPY, humanAntiserum | Details |
| Benzyl N-({[(cyclopropylcarbamoyl)methyl](methyl)carbamoyl}methyl)carbamate | C16H21N3O4 | 1252272-80-2 | Details |
| 2,3,4,6-Tetra-O-acetyl-a-D-galactopyranosyl azide | C14H19N3O9 | 94427-00-6 | Details |
| 1-Chloro-3-methyl-benzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile | C13H8ClN3 | 121105-78-0 | Details |
| SCGF alpha protein | Details |
| 3-(Trifluoromethyl)cyclobutanecarboxylic acid | C6H7F3O2 | 1093750-93-6 | Details |
| 2-Ethoxy-1H-indole | C10H11NO | 1009-27-4 | Details |
| (5-methyl-1,2-oxazol-4-yl)methanamine,hydrochloride | C5H9ClN2O | 1949836-91-2 | Details |
| NARG1 antibody | Details |
| cGK2 antibody | Details |
| S-(+)-α-Methoxy-α-(trifluoromethyl)phenylacetic acid chloride | C10H8ClF3O2 | 20445-33-4 | Details |
| 2-Ethyl-2-propen-1-ol | C5H10O | 4435-54-5 | Details |
| Perilipin (C terminal) antibody | Details |
| Tri-mannuronic acid sodium salt | C18H26O19 | Details |
| 2-(4-Chlorophenyl)piperidine | C11H14ClN | 383128-09-4 | Details |
| (3-Chloro-5-methanesulfonylphenyl)methanamine hydrochloride | C8H11Cl2NO2S | 1192347-69-5 | Details |
| 3-Amino-2-methoxy-benzoic acid methyl ester hydrochloride | C9H12ClNO3 | 1187927-19-0 | Details |
| 4-Chloro-7-fluoro-2,3-dihydro-1H-inden-1-one | C9H6ClFO | 1260018-63-0 | Details |
| beta 2 Microglobulin antibody (biotin) | Details |
| 1-Cyclohexyl-4-iodobenzene | C12H15I | 91639-29-1 | Details |
| 7-Bromo-5-methoxyquinoline | C10H8BrNO | 1378860-76-4 | Details |
| STX7 Blocking Peptide | Details |
| 2-(1-Methylcyclopropyl)aniline hydrochloride | 2172577-83-0 | Details |
| 1,7-Dihydroxy-3-methoxy-2-prenylxanthone | C19H18O5 | 77741-58-3 | Details |
| Ramucirumab | 947687-13-0 | Details |
| 6-Chloro-5-ethylisatin | C10H8ClNO2 | 1379362-81-8 | Details |
| IFT122 antibody | Details |
| Autocamtide-3 Derived Inhibitory Peptide(AC3 - I) | Details |
| (5-Chlorothiophen-2-yl)methanol | C5H5ClOS | 74168-69-7 | Details |
| ATP5D antibody (FITC) | Details |
| [Ile8]-Oxytocin | C43H66N12O12S2 | Details |
| 4-(Dimethylamino)benzophenone | C15H15NO | 530-44-9 | Details |
| (-)-2,3-O-Isopropylidene-D-threitol | C7H14O4 | 73346-74-4 | Details |
| trans,trans-Muconic acid | C6H6O4 | 3588-17-8 | Details |
| 3-(Cyclopropylmethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine | C9H14N4 | 1248069-25-1 | Details |
| 4-Methoxyoxane-4-carbohydrazide | C7H14N2O3 | 1936115-91-1 | Details |
| Spiro[2.3]hexan-4-amine hydrochloride | C6H12ClN | 2306264-06-0 | Details |
| 2-Methoxy-quinoline-3-carbaldehyde | C11H9NO2 | 139549-06-7 | Details |
| Trimethylsulfonium chloride | C3H9ClS | 3086-29-1 | Details |
| Befovacimab | 2156634-62-5 | Details |
| 3-Fluoropropanoic Acid | C3H5FO2 | 461-56-3 | Details |
| OR2T35 antibody | Details |
| 1-(4-Chlorophenyl)-2-cyclopropylethan-1-amine | C11H14ClN | 1251288-53-5 | Details |
| (1S,4aR,6S,8aS)-6-(2-Hydroxypropan-2-yl)-4,8a-dimethyl-2,4a,5,6,7,8-hexahydro-1H-naphthalen-1-ol | C15H26O2 | 658062-22-7 | Details |
| 4-Methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-amine | C6H8F3N3 | 1174876-14-2 | Details |
| 5-(Chloromethyl)-3-[(3-fluorophenyl)methyl]-1,2,4-oxadiazole | C10H8ClFN2O | 1247475-08-6 | Details |
| 2-[3-(But-3-yn-1-yl)-3H-diazirin-3-yl]ethan-1-amine hydrochloride | C7H12ClN3 | 2089291-69-8 | Details |
| 3-Methylglutaric acid | C6H10O4 | 626-51-7 | Details |
| Prothrombin factor II antibody (HRP) | Details |
| 6-tert-butyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2-carboxylate lithium | C12H18LiNO2S | 1803596-74-8 | Details |
| 2-(Cyclopent-1-en-1-yl)propanoic acid | C8H12O2 | 92000-97-0 | Details |
| 3-Methoxy-2,5-dimethylaniline hydrochloride | C9H14ClNO | 861555-59-1 | Details |
| 2-Methoxy-4-phenylcyclohexan-1-one | C13H16O2 | 1803605-45-9 | Details |
| 1-(3,5-Dimethylphenyl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one | C13H12N4O | 852840-43-8 | Details |
| N-Ethyl Benzamid-3-carboxylate | C10H11NO3 | 126926-33-8 | Details |
| 2-(4-tert-Butyl-3-hydroxy-2,6-dimethylphenyl)acetic acid | C14H20O3 | 55699-12-2 | Details |
| 3-{[(4-Fluorophenyl)methyl]amino}benzamide | C14H13FN2O | 1042534-72-4 | Details |
| D-Octahydroindole-2-carboxylic acid | C9H15NO2 | 82717-40-6 | Details |
| 2,3:4,5-Di-O-isopropylidene-D-talonic acid methyl ester | Details |
| 2,2,3,3,3-Pentafluoropropyl carbonochloridate | C4H2ClF5O2 | 1025495-74-2 | Details |
| tert-Butyl 6-amino-2-azabicyclo[2.2.2]octane-2-carboxylate | C12H22N2O2 | 1357352-04-5 | Details |
| L-Tyrosine-(phenyl-d4) | C9H7D4NO3 | 62595-14-6 | Details |
| [1-(2-Phenylethyl)pyrrolidin-2-yl]methanamine | C13H20N2 | 60737-45-3 | Details |
| Kinase Domain of Insulin Receptor (5) | C72H110N19O33P3 | Details |
| TRPC4AP Blocking Peptide | Details |
| [(2-Methoxy-5-methylphenyl)methyl](methyl)amine | C10H15NO | 900641-05-6 | Details |
| 3-{[(tert-Butoxy)carbonyl]amino}oxane-3-carboxylic acid | C11H19NO5 | 1404692-29-0 | Details |
| 4-Iodo-2-methylbutan-2-ol | C5H11IO | 221248-59-5 | Details |
| 1,2,3,4,6-Penta-O-pivaloyl-a-D-glucopyranoside | C31H52O11 | 1213234-53-7 | Details |
| Methyl[1-(oxolan-2-yl)-2-phenylethyl]amine hydrochloride | 92196-03-7 | Details |
| 5-Benzyl-1,3,4-oxadiazole-2-thiol | C9H8N2OS | 23288-90-6 | Details |
| MED22 antibody | Details |
| GNL3 antibody | Details |
| 3-(Benzylsulfanyl)propan-1-ol | C10H14OS | 26902-03-4 | Details |
| (5,5-Dimethyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)methanamine | C11H17NS | 1376224-89-3 | Details |
| 2-Bromo-4-(difluoromethyl)-1,3-thiazole | C4H2BrF2NS | 1545252-82-1 | Details |
| (2-(3,4-dimethoxyphenyl)ethyl)(phenylsulfonyl)amine | C16H19NO4S | 77199-00-9 | Details |
| 4-[(3-Cyclohexyl-1,2,4-oxadiazol-5-yl)methyl]piperidine hydrochloride | C14H24ClN3O | 2031261-24-0 | Details |
| (2S, 3S, 4R) -3- Azido- 4- [[[(1, 1- dimethylethyl) dimethylsilyl] oxy] methyl] - 1- (phenylmethyl) -2- azetidinecarboxylic acid met hyl ester | 1992035-12-7 | Details |
| SEPHS1 antibody | Details |
| But-2-yne-1,4-diamine dihydrochloride | C4H9ClN2 | 26232-80-4 | Details |
| 3-(Difluoromethyl)pyrrolidine-3-carboxylic acid hydrochloride | C6H10ClF2NO2 | 1820674-06-3 | Details |
| Metallophilic Macrophage antibody (biotin) | Details |
| 2-(2-Phenoxyacetamido)benzoic acid | C15H13NO4 | 18704-92-2 | Details |
| 2-Methoxypyridine-3-sulfonamide | C6H8N2O3S | 1566061-98-0 | Details |
| 2-(Cyclohexylamino)-5-nitrobenzene-1-sulfonamide | C12H17N3O4S | 899790-17-1 | Details |
| 2-Chloro-4-phenyl-1,3,5-triazine | C9H6ClN3 | 77007-96-6 | Details |
| RBBP5 Blocking Peptide | Details |
| 1-Benzyl-5-chloro-3-methyl-1H-pyrazole-4-carboxylic acid | C12H11ClN2O2 | 882227-05-6 | Details |
| A1CF Blocking Peptide | Details |
| H-IYPTNGYTR^-OH | Details |
| Product Total： Product Page： | ||||
| 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 | ||||